A top Apple executive reportedly proposed a bid to buy the media group late last year. » Read More
Australia's competition watchdog said Royal Dutch Shell's $70B takeover of BG Group would not change the domestic natural gas market.
Christian Faitz, equity research analyst at Kepler Cheuvreux, explains why Monsanto’s bid to buy Syngenta was more than just the price.
Liberty Media chief John Malone said he wouldn't be surprised to see more media consolidation as global scale becomes important.
Anheuser-Busch InBev completed an agreement to acquire SABMiller for about $105 billion.
AB InBev is poised to announce on Wednesday that it has clinched a deal to buy SABMiller for £68 billion, the Financial Times reports.
Dell's ambitious plan to take over storage giant EMC may face a tax burden that could derail the deal. Re/code reports.
David Solomon, Goldman Sachs, weighs in on this year's blockbuster M&A deals and provides a look at what to expect into 2016. Also Solomon discusses plans to keep junior bankers at the firm longer.
Alex Leyland, portfolio manager at Leyland Private Asset Management, discusses whether Qube or Brookfield stands a better chance of acquiring Australia's Asciano.
Some of those generic pills you buy at the drug store could change ownership Friday.
Forrester predicts the mobile revolution will accelerate in 2016. Who are the winners?
Ken Moelis, Moelis & Co. founder & CEO, talks about the art of dealmaking and current trends in M&A. And Ron Baron, Baron Capital chairman & CEO, weighs in.
DuPont is holding talks with Syngenta and Dow Chemical for a potential deal, as the agriculture world struggles with lower crop prices and profits.
Peter Toogood, investment director at City Financial Investment Company Limited, explains why large pharmaceuticals tend to take over midcap rivals.
Activision Blizzard announced the company would acquire King Digital for $5.9 billion. Here's the user habits that make it such a valuable acquisition.
Kevin McVeigh, managing director and head of U.S. financials at Macquarie Capital, explains why he believes Visa will announce that it will buy Visa Europe on Monday.
Michael O'Leary, CEO of Ryanair, says he prefers organic growth to M&A.
Chris Wei, executive chairman for Asia at Aviva, says the acquisition of Friends Life this year has brought new business growth and improved synergies.
CNBC's David Faber has the update on a potential deal between drugmakers Pfizer and Allergan on the floor of the NYSE.
"Squawk on the Street" David Faber has the update on a potential deal between drugmakers Pfizer and Allergan and the tax benefits that would follow.
Pharmaceutical giants Pfizer and botox maker Allergan are in discussions about a potential takeover deal.